AAAAAA

   
Results: 1-23 |
Results: 23
THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) MEDIATES CLEARANCE OF COAGULATION-FACTOR XA IN-VIVO
Authors: NARITA M RUDOLPH AE MILETICH JP SCHWARTZ AL
Citation: M. Narita et al., THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) MEDIATES CLEARANCE OF COAGULATION-FACTOR XA IN-VIVO, Blood, 91(2), 1998, pp. 555-560
FACTOR-V-LEIDEN MUTATION AS A RISK FACTOR FOR RECURRENT PREGNANCY LOSS
Authors: RIDKER PM MILETICH JP BURING JE ARIYO AA PRICE DT MANSON JE HILL JA
Citation: Pm. Ridker et al., FACTOR-V-LEIDEN MUTATION AS A RISK FACTOR FOR RECURRENT PREGNANCY LOSS, Annals of internal medicine, 128(12), 1998, pp. 1000-1003
EXPRESSION, PURIFICATION, AND CHARACTERIZATION OF RECOMBINANT HUMAN FACTOR-X
Authors: RUDOLPH AE MULLANE MP PORCHESORBET R MILETICH JP
Citation: Ae. Rudolph et al., EXPRESSION, PURIFICATION, AND CHARACTERIZATION OF RECOMBINANT HUMAN FACTOR-X, Protein expression and purification, 10(3), 1997, pp. 373-378
HOT PAPERS - PATHOLOGY - MUTATION IN THE GENE CODING FOR COAGULATION-FACTOR V AND THE RISK OF MYOCARDIAL-INFARCTION, STROKE, AND VENOUS THROMBOSIS IN APPARENTLY HEALTHY-MEN BY RIDKER,P.M., HENNEKENS,C.H., LINDPAINTNER,K., STAMPFER,M.J., EISENBERG,P.R., MILETICH,J.P. - COMMENTS
Authors: MILETICH JP
Citation: Jp. Miletich, HOT PAPERS - PATHOLOGY - MUTATION IN THE GENE CODING FOR COAGULATION-FACTOR V AND THE RISK OF MYOCARDIAL-INFARCTION, STROKE, AND VENOUS THROMBOSIS IN APPARENTLY HEALTHY-MEN BY RIDKER,P.M., HENNEKENS,C.H., LINDPAINTNER,K., STAMPFER,M.J., EISENBERG,P.R., MILETICH,J.P. - COMMENTS, The Scientist, 11(13), 1997, pp. 11-11
PREVALENCE OF FACTOR-V-LEIDEN IN ACCELERATED FORMS OF CORONARY-ARTERYDISEASE
Authors: FANG JC MILETICH JP RIDKER PM
Citation: Jc. Fang et al., PREVALENCE OF FACTOR-V-LEIDEN IN ACCELERATED FORMS OF CORONARY-ARTERYDISEASE, Thrombosis and haemostasis, 78(3), 1997, pp. 1161-1162
INHERITED THROMBOPHILIA .2. (VOL 76, PG 824, 1996)
Authors: LANE DA MANNUCCI PM BAUER KA BERTINA RM BOCHKOV NP BOULYJENKOV V CHANDY M DAHLBACK B GINTER EK MILETICH JP ROSENDAAL FR SELIGSOHN U
Citation: Da. Lane et al., INHERITED THROMBOPHILIA .2. (VOL 76, PG 824, 1996), Thrombosis and haemostasis, 77(5), 1997, pp. 1047-1047
ETHNIC DISTRIBUTION OF FACTOR-V-LEIDEN IN 4047 MEN AND WOMEN - IMPLICATIONS FOR VENOUS THROMBOEMBOLISM SCREENING
Authors: RIDKER PM MILETICH JP HENNEKENS CH BURING JE
Citation: Pm. Ridker et al., ETHNIC DISTRIBUTION OF FACTOR-V-LEIDEN IN 4047 MEN AND WOMEN - IMPLICATIONS FOR VENOUS THROMBOEMBOLISM SCREENING, JAMA, the journal of the American Medical Association, 277(16), 1997, pp. 1305-1307
INTERRELATION OF HYPERHOMOCYST(E)INEMIA, FACTOR-V LEIDEN, AND RISK OFFUTURE VENOUS THROMBOEMBOLISM
Authors: RIDKER PM HENNEKENS CH SELHUB J MILETICH JP MALINOW MR STAMPFER MJ
Citation: Pm. Ridker et al., INTERRELATION OF HYPERHOMOCYST(E)INEMIA, FACTOR-V LEIDEN, AND RISK OFFUTURE VENOUS THROMBOEMBOLISM, Circulation, 95(7), 1997, pp. 1777-1782
ARTERIAL AND VENOUS THROMBOSIS IS NOT ASSOCIATED WITH THE 4G 5G POLYMORPHISM IN THE PROMOTER OF THE PLASMINOGEN-ACTIVATOR INHIBITOR GENE INA LARGE COHORT OF US MEN/
Authors: RIDKER PM HENNEKENS CH LINDPAINTNER K STAMPFER MJ MILETICH JP
Citation: Pm. Ridker et al., ARTERIAL AND VENOUS THROMBOSIS IS NOT ASSOCIATED WITH THE 4G 5G POLYMORPHISM IN THE PROMOTER OF THE PLASMINOGEN-ACTIVATOR INHIBITOR GENE INA LARGE COHORT OF US MEN/, Circulation, 95(1), 1997, pp. 59-62
AGE-SPECIFIC INCIDENCE RATES OF VENOUS THROMBOEMBOLISM AMONG HETEROZYGOUS CARRIERS OF FACTOR-V LEIDEN MUTATION
Authors: RIDKER PM GLYNN RJ MILETICH JP GOLDHABER SZ STAMPFER MJ HENNEKENS CH
Citation: Pm. Ridker et al., AGE-SPECIFIC INCIDENCE RATES OF VENOUS THROMBOEMBOLISM AMONG HETEROZYGOUS CARRIERS OF FACTOR-V LEIDEN MUTATION, Annals of internal medicine, 126(7), 1997, pp. 528-531
THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) MEDIATES CLEARANCE OF COAGULATION-FACTOR XA IN-VIVO
Authors: NARITA M RUDOLPH AE MILETICH JP SCHWARTZ AL
Citation: M. Narita et al., THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) MEDIATES CLEARANCE OF COAGULATION-FACTOR XA IN-VIVO, Molecular biology of the cell, 7, 1996, pp. 1552-1552
INHERITED THROMBOPHILIA .2.
Authors: LANE DA MANNUCCI PM BAUER KA BERTINA RM BOCHKOV NP BOULYJENKOV V CHANDY M DAHLBACK B GINTER EK MILETICH JP ROSENDAAL FR SELIGSOHN U
Citation: Da. Lane et al., INHERITED THROMBOPHILIA .2., Thrombosis and haemostasis, 76(6), 1996, pp. 824-834
INHERITED THROMBOPHILIA .1.
Authors: LANE DA MANNUCCI PM BAUER KA BERTINA RM BOCHKOV NP BOULYJENKOV V CHANDY M DAHLBACK B GINTER EK MILETICH JP ROSENDAAL FR SELIGSOHN U
Citation: Da. Lane et al., INHERITED THROMBOPHILIA .1., Thrombosis and haemostasis, 76(5), 1996, pp. 651-662
FACTOR X(ST LOUIS II) - IDENTIFICATION OF A GLYCINE SUBSTITUTION AT RESIDUE-7 AND CHARACTERIZATION OF THE RECOMBINANT PROTEIN
Authors: RUDOLPH AE MULLANE MP PORCHESORBET R TSUDA S MILETICH JP
Citation: Ae. Rudolph et al., FACTOR X(ST LOUIS II) - IDENTIFICATION OF A GLYCINE SUBSTITUTION AT RESIDUE-7 AND CHARACTERIZATION OF THE RECOMBINANT PROTEIN, The Journal of biological chemistry, 271(45), 1996, pp. 28601-28606
ETHNIC DISTRIBUTION OF ACTIVATED PROTEIN-C RESISTANCE AMONG AMERICAN WOMEN
Authors: RIDKER PM HENNEKENS CH MILETICH JP BURING JE
Citation: Pm. Ridker et al., ETHNIC DISTRIBUTION OF ACTIVATED PROTEIN-C RESISTANCE AMONG AMERICAN WOMEN, Circulation, 94(8), 1996, pp. 65-65
PLASMA HOMOCYSTEINE LEVEL, FACTOR-V LEIDEN, AND RISKS OF FUTURE VENOUS THROMBOEMBOLISM
Authors: RIDKER PM MILETICH JP HENNEKENS CH STAMPFER MJ
Citation: Pm. Ridker et al., PLASMA HOMOCYSTEINE LEVEL, FACTOR-V LEIDEN, AND RISKS OF FUTURE VENOUS THROMBOEMBOLISM, Circulation, 94(8), 1996, pp. 4066-4066
IMPROVED DISCRIMINATION FOR FV-R(506) Q-MUTATION USING MODIFIED ACTIVATED PROTEIN-C RESISTANCE ASSAY
Authors: EBY CS PORCHESORBET R RIDKER PM MILETICH JP
Citation: Cs. Eby et al., IMPROVED DISCRIMINATION FOR FV-R(506) Q-MUTATION USING MODIFIED ACTIVATED PROTEIN-C RESISTANCE ASSAY, Blood, 88(10), 1996, pp. 3047-3047
MUTATION IN THE GENE CODING FOR COAGULATION-FACTOR-V AND THE RISK OF MYOCARDIAL-INFARCTION, STROKE, AND VENOUS THROMBOSIS IN APPARENTLY HEALTHY-MEN
Authors: RIDKER PM HENNEKENS CH LINDPAINTER K STAMPFER MJ EISENBERG PR MILETICH JP
Citation: Pm. Ridker et al., MUTATION IN THE GENE CODING FOR COAGULATION-FACTOR-V AND THE RISK OF MYOCARDIAL-INFARCTION, STROKE, AND VENOUS THROMBOSIS IN APPARENTLY HEALTHY-MEN, The New England journal of medicine, 332(14), 1995, pp. 912-917
ESTIMATED RISKS OF VENOUS THROMBOSIS ASSOCIATED WITH FACTOR-V LEIDEN APPEAR TO MARKEDLY INCREASE WITH AGE
Authors: RIDKER PM GLYNN RJ EISENBERG PR MILETICH JP STAMPFER MJ HENNEKENS CH
Citation: Pm. Ridker et al., ESTIMATED RISKS OF VENOUS THROMBOSIS ASSOCIATED WITH FACTOR-V LEIDEN APPEAR TO MARKEDLY INCREASE WITH AGE, Circulation, 92(8), 1995, pp. 1994-1994
IMPORTANCE OF PLATELETS IN ARTERIAL CLOT-ASSOCIATED PROCOAGULANT ACTIVITY
Authors: EISENBERG PR LEE J MILETICH JP
Citation: Pr. Eisenberg et al., IMPORTANCE OF PLATELETS IN ARTERIAL CLOT-ASSOCIATED PROCOAGULANT ACTIVITY, Circulation, 92(8), 1995, pp. 3865-3865
FACTOR-V LEIDEN AND RISKS OF RECURRENT IDIOPATHIC VENOUS THROMBOEMBOLISM
Authors: RIDKER PM MILETICH JP STAMPFER MJ GOLDHABER SZ LINDPAINTNER K HENNEKENS CH
Citation: Pm. Ridker et al., FACTOR-V LEIDEN AND RISKS OF RECURRENT IDIOPATHIC VENOUS THROMBOEMBOLISM, Circulation, 92(10), 1995, pp. 2800-2802
ASPARAGINE FOR ARGININE SUBSTITUTION AT RESIDUE-347 OF RECOMBINANT FACTOR XA REDUCES AFFINITY FOR FACTOR VA
Authors: RUDOLPH AE MILETICH JP
Citation: Ae. Rudolph et Jp. Miletich, ASPARAGINE FOR ARGININE SUBSTITUTION AT RESIDUE-347 OF RECOMBINANT FACTOR XA REDUCES AFFINITY FOR FACTOR VA, Blood, 86(10), 1995, pp. 279-279
IMPORTANCE OF FACTOR-XA IN DETERMINING THE PROCOAGULANT ACTIVITY OF WHOLE-BLOOD CLOTS
Authors: EISENBERG PR SIEGEL JE ABENDSCHEIN DR MILETICH JP
Citation: Pr. Eisenberg et al., IMPORTANCE OF FACTOR-XA IN DETERMINING THE PROCOAGULANT ACTIVITY OF WHOLE-BLOOD CLOTS, The Journal of clinical investigation, 91(5), 1993, pp. 1877-1883
Risultati: 1-23 |